SCHEMBL9908232

SCHEMBL9908232

CC(C)N(c1ccc(Cl)cc1Cl)C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 1/20 0.42
HTT P42858 2/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
FSCN1 Q16658 1/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
CYP2C19 P33261 1/20 0.38
PSEN1 P49768 4/20 0.37
PSEN2 P49810 4/20 0.37
APH1B Q8WW43 4/20 0.37
NCSTN Q92542 4/20 0.37
APH1A Q96BI3 4/20 0.37
PSENEN Q9NZ42 4/20 0.37
SLC6A2 P23975 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9909358 0.79 NPC1 (0.48) NPC1RAB9ATP53FSCN1NPSR1
Hydrochloric Acid SCHEMBL1432259 0.76 RAB9A (0.41) NPC1RAB9AHTTLMNATP53
SCHEMBL12744415 0.75 TSHR (0.43) NPC1RAB9AHTTLMNATP53
SCHEMBL12715258 0.75 NPC1 (0.45) NPC1RAB9ALMNAFSCN1NPSR1
SCHEMBL9908231 0.69 FSCN1 (0.52) RAB9AHTTLMNATP53FSCN1
SCHEMBL11774055 0.68 GAA (0.37) NPC1RAB9AHTTLMNATP53
SCHEMBL11650028 0.67 NOS2 (0.54) HTTLMNAMEN1KMT2ACYP1A2
SCHEMBL17914507 0.67 CYP2D6 (0.54) CYP2C19PSEN1PSEN2APH1BNCSTN
Nitrogen SCHEMBL10788138 0.67 NPC1 (0.43) NPC1RAB9ATP53MEN1KMT2A
SCHEMBL30936610 0.67 KMT2A (0.54) NPC1RAB9AHTTLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420689-B2 Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation GLENMARK PHARMACEUTICALS S.A. (CH) 2013-04-16 US disclosed
US-20120142748-A1 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS S.A. (CH) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142748-A1 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION CNR1, CNR2, GPR18 NPC1 539/4885RAB9A 965/4885HTT 2719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.